The clinical features of OSTM1-associated malignant infantile osteopetrosis: A retrospective, single-center experience over one decade.

Szczegóły
Abstrakt

Tytuł:: The clinical features of OSTM1-associated malignant infantile osteopetrosis: A retrospective, single-center experience over one decade.
Autorzy:: Alotaibi Q; Pediatric Department, Aladan Hospital, Al-Masayel, Kuwait.
Dighe M; Pediatric Department, Aladan Hospital, Al-Masayel, Kuwait.
Aldaihani S; Pediatric Department, Aladan Hospital, Al-Masayel, Kuwait.
Źródło:: American journal of medical genetics. Part A [Am J Med Genet A] 2023 Feb; Vol. 191 (2), pp. 459-468. Date of Electronic Publication: 2022 Nov 11.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
Język:: English
Imprint Name(s):: Publication: Hoboken, N.J. : Wiley-Blackwell
Original Publication: Hoboken, N.J. : Wiley-Liss, c2003-
MeSH Terms:: Neurodegenerative Diseases*/genetics
Osteopetrosis*/diagnosis
Osteopetrosis*/genetics
Osteopetrosis*/complications
Female ; Humans ; Infant ; Male ; Homozygote ; Membrane Proteins/genetics ; Retrospective Studies ; Sequence Deletion ; Ubiquitin-Protein Ligases/genetics
References:: Abinun, M., Newson, T., Rowe, P. W., Flood, T. J., & Cant, A. J. (1999). Importance of neurological assessment before bone marrow transplantation for osteopetrosis. Archives of Disease in Childhood, 80(3), 273-274. https://doi.org/10.1136/adc.80.3.273.
Adel, A. M., Abdullah, A. A. J., & Eissa, F. (2013). Infantile osteopetrosis, craniosynostosis, and Chiari malformation type I with novel OSTEM1 mutation. Journal of Pediatric Neurosciences, 8(1), 34-37.
Al-Mofada, S. M., Mahdi, A. H., Vijaykumar, E., & Familusi, J. B. (1993). Infantile malignant osteopetrosis presenting as bilateral choanal atresia: Report of two cases. Annals of Saudi Medicine, 13(1), 81-84.
Alotaibi, Q., & Dighe, M. (2021). Managing challenging pain and irritability in OSTM1 mutation-related infantile malignant osteopetrosis. BML Case Reports, 14(5), e242498. https://doi.org/10.1136/bcr-2021-242498.
Alroy, J., Pfannl, R., Ucci, A., Lefranc, G., Frattini, A., & Megarbane, A. (2007). Electron microscopic findings in skin biopsies from patients with infantile osteopetrosis and neuronal storage disease. Ultrastructural Pathology, 31(5), 333-338. https://doi.org/10.1080/01913120701578098.
Askmyr, M. K., Fasth, A., & Richter, J. (2008). Towards a better understanding and new therapeutics of osteopetrosis. British Journal of Haematology, 140(6), 597-609. https://doi.org/10.1111/j.1365-2141.2008.06983.x.
Balemans, W., Van Wesenbeeck, L., & Van Hul, W. (2005). A clinical and molecular overview of the human osteopetroses. Calcified Tissue International, 77(5), 263-274. https://doi.org/10.1007/s00223-005-0027-6.
Barrallo-Gimeno, A., Gradogna, A., Zanardi, I., Pusch, M., & Estevez, R. (2015). Regulatory-auxiliary subunits of CLC chloride channel-transport proteins. The Journal of Physiology, 593(18), 4111-4127. https://doi.org/10.1113/JP270057.
Bubshait, D. K., Himdy, Z. E., Fadaaq, O., & Alshmas, H. I. (2020). Malignant infantile osteopetrosis: A case report. Cureus, 12(1), e6725. https://doi.org/10.7759/cureus.6725.
Chalhoub, N., Benachenhou, N., Rajapurohitam, V., Pata, M., Ferron, M., Frattini, A., Villa, A., & Vacher, J. (2003). Grey-lethal mutation induces severe malignant autosomal recessive osteopetrosis in mouse and human. Nature Medicine, 9(4), 399-406. https://doi.org/10.1038/nm842.
Chiodo, D. C., DiRocco, M., Gandolfo, C., Morana, G., Buzzi, D., & Rossi, A. (2007). Neuroimaging findings in malignant infantile osteopetrosis due to OSTM1 mutations. Neuropediatrics, 38(3), 154-156.
CoPAo, C., & Health, F. (2001). The assessment and management of acute pain in infants, children, and adolescents. Pediatrics, 108(3), 793-797.
di Palmo, E., Gallucci, M., Tronconi, E., Bergamaschi, R., Cazzato, S., La Scola, C., Ricci, G., & Pession, A. (2018). Carbonic anhydrase II deficiency: A rare case of severe obstructive sleep apnea. Frontiers in Pediatrics, 6, 213. https://doi.org/10.3389/fped.2018.00213.
Fitzcharles, M. A., Cohen, S. P., Clauw, D. J., Littlejohn, G., Usui, C., & Hauser, W. (2021). Nociplastic pain: Towards an understanding of prevalent pain conditions. Lancet, 397(10289), 2098-2110. https://doi.org/10.1016/S0140-6736(21)00392-5.
Frattini, A., Pangrazio, A., Susani, L., Sobacchi, C., Mirolo, M., Abinun, M., Andolina, M., Flanagan, A., Horwitz, E. M., Mihci, E., Notarangelo, L. D., Ramenghi, U., Teti, A., van Hove, J., Vujic, D., Young, T., Albertini, A., Orchard, P. J., Vezzoni, P., & Villa, A. (2003). Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis. Journal of Bone and Mineral Research, 18(10), 1740-1747. https://doi.org/10.1359/jbmr.2003.18.10.1740.
Hauer, J., Houtrow, A. J., Section On, H., & Palliative Medicine, C. O. C. W. D. (2017). Pain assessment and treatment in children with significant impairment of the central nervous system. Pediatrics, 139(6), 5-11. https://doi.org/10.1542/peds.2017-1002.
Heraud, C., Griffiths, A., Pandruvada, S. N., Kilimann, M. W., Pata, M., & Vacher, J. (2014). Severe neurodegeneration with impaired autophagy mechanism triggered by ostm1 deficiency. The Journal of Biological Chemistry, 289(20), 13912-13925. https://doi.org/10.1074/jbc.M113.537233.
Herebian, D., Alhaddad, B., Seibt, A., Schwarzmayr, T., Danhauser, K., Klee, D., Harmsen, S., Meitinger, T., Strom, T. M., Schulz, A., Mayatepek, E., Haack, T. B., & Distelmaier, F. (2017). Coexisting variants in OSTM1 and MANEAL cause a complex neurodegenerative disorder with NBIA-like brain abnormalities. European Journal of Human Genetics, 25(9), 1092-1095. https://doi.org/10.1038/ejhg.2017.96.
Hoyoux, C., Dresse, M. F., Forget, P., Piette, C., Rausin, L., Villa, A., Gothot, A., & Florkin, B. (2014). Osteopetrosis mimicking juvenile myelomonocytic leukemia. Pediatrics International, 56(5), 779-782. https://doi.org/10.1111/ped.12342.
International Association for the Study of Pain (IASP). (2022). International association for the study of pain. https://www.iasp-pain.org. Accessed March 10, 2022.
Jain, A. A., Yeluri, R., & Munshi, A. K. (2012). Measurement and assessment of pain in children-A review. The Journal of Clinical Pediatric Dentistry, 37(2), 125-136. https://doi.org/10.17796/jcpd.37.2.k84341490806t770.
Jain, M., Mittal, P., Shukla, A., & Kumar, A. (2017). Osteopetrosis in twin infants mimicking leukemia. Revista Brasileira de Hematologia e Hemoterapia, 39(4), 372-374. https://doi.org/10.1016/j.bjhh.2017.06.002.
Kasow, K. A., Stocks, R. M. S., Kaste, S. C., Donepudi, S., Tottenham, D., Schoumacher, R. A., & Horwitz, E. M. (2008). Airway evaluation and management in 7 children with malignant infantile osteopetrosis before hematopoietic stem cell transplantation. Journal of Pediatric Hematology/Oncology, 30(3), 225-229.
Lange, P. F., Wartosch, L., Jentsch, T. J., & Fuhrmann, J. C. (2006). ClC-7 requires Ostm1 as a β-subunit to support bone resorption and lysosomal function. Nature, 440(7081), 220-223.
Latremoliere, A., & Woolf, C. J. (2009). Central sensitization: A generator of pain hypersensitivity by central neural plasticity. The Journal of Pain, 10(9), 895-926. https://doi.org/10.1016/j.jpain.2009.06.012.
Leisle, L., Ludwig, C. F., Wagner, F. A., Jentsch, T. J., & Stauber, T. (2011). ClC-7 is a slowly voltage-gated 2Cl−/1H+-exchanger and requires Ostm1 for transport activity. The EMBO Journal, 30(11), 2140-2152.
Liu, C., Ajmal, M., Akram, Z., Ghafoor, T., Farhan, M., Shafique, S., Wahid, S., Bano, S., Xiao, J., Satti, H. S., Zhang, F., & Khan, T. N. (2021). Genetic analysis of osteopetrosis in Pakistani families identifies novel and known sequence variants. BMC Medical Genomics, 14(1), 264. https://doi.org/10.1186/s12920-021-01117-4.
Maranda, B., Chabot, G., Decarie, J. C., Pata, M., Azeddine, B., Moreau, A., & Vacher, J. (2008). Clinical and cellular manifestations of OSTM1-related infantile osteopetrosis. Journal of Bone and Mineral Research, 23(2), 296-300. https://doi.org/10.1359/jbmr.071015.
Mathews, L. (2011). Pain in children: Neglected, unaddressed and mismanaged. Indian Journal of Palliative Care, 17(Suppl), S70-S73. https://doi.org/10.4103/0973-1075.76247.
Mazzolari, E., Forino, C., Razza, A., Porta, F., Villa, A., & Notarangelo, L. D. (2009). A single-center experience in 20 patients with infantile malignant osteopetrosis. American Journal of Hematology, 84(8), 473-479. https://doi.org/10.1002/ajh.21447.
Nijs, J., Lahousse, A., Kapreli, E., Bilika, P., Saracoglu, I., Malfliet, A., Coppieters, I., De Baets, L., Leysen, L., Roose, E., Clark, J., Voogt, L., & Huysmans, E. (2021). Nociplastic pain criteria or recognition of central sensitization? Pain phenotyping in the past, present and future. Journal of Clinical Medicine, 10(15), 3203. https://doi.org/10.3390/jcm10153203.
Ott, C.-E., Fischer, B., Schröter, P., Richter, R., Gupta, N., Verma, N., Kabra, M., Mundlos, S., Rajab, A., Neitzel, H., & Kornak, U. (2013). Severe neuronopathic autosomal recessive osteopetrosis due to homozygous deletions affecting OSTM1. Bone, 55(2), 292-297.
Overholt, K. M., Rose, M. J., Joshi, S., Herman, G. E., Bajwa, R., Abu-Arja, R., Rangarajan, H. G., & Horwitz, E. M. (2017). Hematopoietic cell transplantation for a child with OSTM1 osteopetrosis. Blood Advances, 1(4), 279-281. https://doi.org/10.1182/bloodadvances.2016002345.
Pangrazio, A., Poliani, P. L., Megarbane, A., Lefranc, G., Lanino, E., Di Rocco, M., Rucci, F., Lucchini, F., Ravanini, M., Facchetti, F., Abinun, M., Vezzoni, P., Villa, A., & Frattini, A. (2006). Mutations in OSTM1 (grey lethal) define a particularly severe form of autosomal recessive osteopetrosis with neural involvement. Journal of Bone and Mineral Research, 21(7), 1098-1105. https://doi.org/10.1359/jbmr.060403.
Pata, M., Heraud, C., & Vacher, J. (2008). OSTM1 bone defect reveals an intercellular hematopoietic crosstalk. The Journal of Biological Chemistry, 283(45), 30522-30530. https://doi.org/10.1074/jbc.M805242200.
Penna, S., Capo, V., Palagano, E., Sobacchi, C., & Villa, A. (2019). One disease, many genes: Implications for the treatment of Osteopetroses. Frontiers in Endocrinology (Lausanne), 10, 85. https://doi.org/10.3389/fendo.2019.00085.
Pressey, S. N., O'Donnell, K. J., Stauber, T., Fuhrmann, J. C., Tyynela, J., Jentsch, T. J., & Cooper, J. D. (2010). Distinct neuropathologic phenotypes after disrupting the chloride transport proteins ClC-6 or ClC-7/Ostm1. Journal of Neuropathology and Experimental Neurology, 69(12), 1228-1246. https://doi.org/10.1097/NEN.0b013e3181ffe742.
Prinetti, A., Rocchetta, F., Costantino, E., Frattini, A., Caldana, E., Rucci, F., Bettiga, A., Poliani, P. L., Chigorno, V., & Sonnino, S. (2009). Brain lipid composition in grey-lethal mutant mouse characterized by severe malignant osteopetrosis. Glycoconjugate Journal, 26(6), 623-633. https://doi.org/10.1007/s10719-008-9179-8.
Quarello, P., Forni, M., Barberis, L., Defilippi, C., Campagnoli, M. F., Silvestro, L., Frattini, A., Chalhoub, N., Vacher, J., & Ramenghi, U. (2004). Severe malignant osteopetrosis caused by a GL gene mutation. Journal of Bone and Mineral Research, 19(7), 1194-1199. https://doi.org/10.1359/JBMR.040407.
Ramirez, A., Faupel, J., Goebel, I., Stiller, A., Beyer, S., Stöckle, C., Hasan, C., Bode, U., Kornak, U., & Kubisch, C. (2004). Identification of a novel mutation in the coding region of the grey-lethal gene OSTM1 in human malignant infantile osteopetrosis. Human Mutation, 23(5), 471-476. https://doi.org/10.1002/humu.20028.
Rasmussen, L. A., & Gregoire, M. C. (2015). Challenging neurological symptoms in paediatric palliative care: An approach to symptom evaluation and management in children with neurological impairment. Paediatrics & Child Health, 20(3), 159-165. https://doi.org/10.1093/pch/20.3.159.
Sartelet, A., Stauber, T., Coppieters, W., Ludwig, C. F., Fasquelle, C., Druet, T., Zhang, Z., Ahariz, N., Cambisano, N., Jentsch, T. J., & Charlier, C. (2014). A missense mutation accelerating the gating of the lysosomal Cl-/H+-exchanger ClC-7/Ostm1 causes osteopetrosis with gingival hamartomas in cattle. Disease Models & Mechanisms, 7(1), 119-128. https://doi.org/10.1242/dmm.012500.
Shin, B., Yu, J., Park, E.-S., Choi, S., Yu, J., Hwang, J. M., Yun, H., Chung, Y. H., Hong, K. S., Choi, J. S., Takami, M., & Rho, J. (2014). Secretion of a truncated osteopetrosis-associated transmembrane protein 1 (OSTM1) mutant inhibits osteoclastogenesis through down-regulation of the B lymphocyte-induced maturation protein 1 (BLIMP1)-nuclear factor of activated T cells c1 (NFATc1) axis. The Journal of Biological Chemistry, 289(52), 35868-35881.
Sobacchi, C., Schulz, A., Coxon, F. P., Villa, A., & Helfrich, M. H. (2013). Osteopetrosis: Genetics, treatment and new insights into osteoclast function. Nature Reviews Endocrinology, 9(9), 522-536.
Souraty, N., Noun, P., Djambas-Khayat, C., Chouery, E., Pangrazio, A., Villa, A., Lefranc, G., Frattini, A., & Mégarbané, A. (2007). Molecular study of six families originating from the Middle-East and presenting with autosomal recessive osteopetrosis. European Journal of Medical Genetics, 50(3), 188-199. https://doi.org/10.1016/j.ejmg.2007.01.005.
Stark, Z., & Savarirayan, R. (2009). Osteopetrosis. Orphanet Journal of Rare Diseases, 4(1), 5. https://doi.org/10.1186/1750-1172-4-5.
Strauss, A., Furlan, I., Steinmann, S., Buchholz, B., Kremens, B., Rossig, C., Corbacioglu, S., Rajagopal, R., Lahr, G., Yoshimi, A., Strahm, B., Niemeyer, C. M., & Schulz, A. (2015). Unmistakable morphology? Infantile malignant Osteopetrosis resembling juvenile Myelomonocytic leukemia in infants. The Journal of Pediatrics, 167(2), 486-488. https://doi.org/10.1016/j.jpeds.2015.04.064.
Vacher, J., Bruccoleri, M., & Pata, M. (2020). Ostm1 from mouse to human: Insights into osteoclast maturation. International Journal of Molecular Sciences, 21(16), 5600.
Villa, A., Guerrini, M. M., Cassani, B., Pangrazio, A., & Sobacchi, C. (2009). Infantile malignant, autosomal recessive osteopetrosis: The rich and the poor. Calcified Tissue International, 84(1), 1-12. https://doi.org/10.1007/s00223-008-9196-4.
Walker, S. M. (2020). Neuropathic pain in children: Steps towards improved recognition and management. eBioMedicine, 62, 103124. https://doi.org/10.1016/j.ebiom.2020.103124.
Weinert, S., Jabs, S., Hohensee, S., Chan, W. L., Kornak, U., & Jentsch, T. J. (2014). Transport activity and presence of ClC-7/Ostm1 complex account for different cellular functions. EMBO Reports, 15(7), 784-791. https://doi.org/10.15252/embr.201438553.
Wu, C. C., Econs, M. J., DiMeglio, L. A., Insogna, K. L., Levine, M. A., Orchard, P. J., et al. (2017). Diagnosis and management of osteopetrosis: Consensus guidelines from the Osteopetrosis Working Group. The Journal of Clinical Endocrinology and Metabolism, 102(9), 3111-3123. https://doi.org/10.1210/jc.2017-01127.
Zernikow, B., Wager, J., Hechler, T., Hasan, C., Rohr, U., Dobe, M., Meyer, A., Hübner-Möhler, B., Wamsler, C., & Blankenburg, M. (2012). Characteristics of highly impaired children with severe chronic pain: A 5-year retrospective study on 2249 pediatric pain patients. BMC Pediatrics, 12(1), 54. https://doi.org/10.1186/1471-2431-12-54.
Contributed Indexing:: Keywords: OSTM1; neurodegeneration; osteopetrosis; pain; palliative care
Substance Nomenclature:: 0 (Membrane Proteins)
0 (OSTM1 protein, human)
EC 2.3.2.27 (Ubiquitin-Protein Ligases)
Entry Date(s):: Date Created: 20221112 Date Completed: 20230206 Latest Revision: 20230221
Update Code:: 20240105
DOI:: 10.1002/ajmg.a.63042
PMID:: 36369659
: Czasopismo naukowe

Full Text Finder

Mutation in OSTM1 give rise to the rarest and most lethal subtype of malignant infantile osteopetrosis (MIOP), and an improved understanding of OSTM1-associated MIOP would help with informed decision-making regarding symptom management and early palliative care referral. This retrospective study describes the clinical and laboratory features of patients with a genetic diagnosis of OSTM1 MIOP made between January 2011 and December 2021 in the Department of Pediatrics, Al-Adan Hospital, Kuwait. Twenty-two children had confirmed homozygous deletion in OSTM1 (13 females, nine males). Consanguinity was reported in almost all parents. 72.7% were diagnosed before the age of two months, most commonly incidentally with a high clinical suspicion. All 22 patients developed upper respiratory symptoms, hepatosplenomegaly, poor feeding, and had severe developmental delay. 80% of patients developed pain and/or irritability, and 40.9% were diagnosed with primary seizures. Bone fractures developed in 27% of patients, most likely iatrogenic, and some patients had hernia and gum abnormalities. The mean survival was 10.9 months. The clinical presentation, symptomatology, and mortality of our cohort were compared with other cases of OSTM1 MIOP identified through a comperhensive search of the PubMed database. The findings conclude that OSTM1 MIOP is a multi-systemic disease with distinct clinical features, of which neurological complications are the most severe and include nociplastic pain and irritability. Although orthopedic complications influence the trajectory of most patients with other forms of osteopetrosis, OSTM1 MIOP is driven by its neurological complications. Hence, OSTM1 should be regarded as a neurodegenerative disease with osteopetrosis as a comorbidity that warrants early palliative care referral.
(© 2022 Wiley Periodicals LLC.)

Informacja